CHIESI Farmaceutici

Chippenham, United Kingdom Founded: 1935 • Age: 91 yrs
Develops innovative therapies for respiratory and rare diseases.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 9 Brand Intelligence

About CHIESI Farmaceutici

CHIESI Farmaceutici is a company based in Chippenham (United Kingdom) founded in 1935. It operates as a B2B. CHIESI Farmaceutici operates in a competitive market with competitors including aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others.

  • Headquarter Chippenham, United Kingdom
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of CHIESI Farmaceutici

Premium access

Detailed funding history for CHIESI Farmaceutici

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CHIESI Farmaceutici

Investments
Premium access

Investment portfolio details for CHIESI Farmaceutici

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - CHIESI Farmaceutici

Premium access

Detailed financials for CHIESI Farmaceutici

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Chiesi Farmaceutici Comparisons

CHIESI Farmaceutici Primary company
Description
Develops innovative therapies for respiratory and rare disea...
Location
Chippenham, United Kingdom
Founded Year
1935
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for CHIESI Farmaceutici

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of CHIESI Farmaceutici

CHIESI Farmaceutici operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as aTyr Pharma, ReCode Therapeutics, GEn1E, Enterprise Therapeutics and Ikaria, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Protein biologics are developed for treating rare diseases.
Locked Locked Locked
Precision medicines for lung-related diseases are developed.
Locked Locked Locked
Developer of therapeutics for the treatment of inflammatory and rare diseases
Locked Locked Locked
Developer of therapeutic solutions for the treatment of respiratory diseases such as cystic fibrosis
Locked Locked Locked
Therapies for respiratory-related cardiopulmonary disorders are developed.
Locked Locked Locked
Respiratory disease drugs for asthma and COPD are developed.
Premium access

Detailed competitors of CHIESI Farmaceutici

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Chiesi Farmaceutici

Premium access

Complete news archive for CHIESI Farmaceutici

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CHIESI Farmaceutici

CHIESI Farmaceutici was founded in 1935.

CHIESI Farmaceutici is headquartered in Chippenham, United Kingdom.

CHIESI Farmaceutici, established in 1935 and currently in Dissolved stage, focuses on providing healthcare solutions, producing pharmaceutical products, drug development, and respiratory and rare diseases therapies. Develops innovative therapies for respiratory and rare diseases. Adapting to market demands with innovation and client-focused strategies.

CHIESI Farmaceutici's top competitors include aTyr Pharma, ReCode Therapeutics and Pulmatrix.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available